Adenovir Pharma
EKC - a highly contagious infectious disease | Adenovir Pharma.
Launch date
Employees
Market cap
-
Enterprise valuation
$3—5m (Dealroom.co estimates Jun 2010.)
Company register number 556745-9986
Göteborgs Stad Västra Götaland County (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenues | <1m | - | - | - | - |
| EBITDA | - | - | (<1m) | (<1m) | (<1m) |
| Profit | (<1m) | (1.6m) | (4.4m) | (<1m) | (<1m) |
| % profit margin | (1017 %) | - | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$790k | Early VC | ||
| Total Funding | $790k | ||
Related Content
Recent News about Adenovir Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.